Scientific Advisory Board
The SAB, made up of recognized experts Dr. Ed Schnipper, Dr. Mark Rodger Stein and Dr. Angela Genge, strengthens ARG’s leadership and expertise in key therapeutic areas: oncology, immunology, rare and neurodegenerative diseases.

Dr. Ed Schnipper
Oncology
“I am excited to work with ARG because of our mutual commitment to pursue scientific advancements leading toward new, approved medicines for patients.”

Dr. Mark Rodger Stein
Immunology
“Immunology research is highly specialized, requiring multidisciplinary relationships and wide-ranging experience. ARG has the talent and expertise to execute the complex clinical trials needed in this field.”

Dr. Angela Genge
Rare and Neurodegenerative Diseases
“ARG’s specializations in both rare and neurodegenerative disease clinical trials create a valuable knowledge base and a collaborative environment in which we can innovate effectively together.”